US Broker Ratings

Haleon plc (HLN) Stock Analysis: A 17.23% Potential Upside Catches Investor Attention

Haleon plc (HLN), a prominent player in the healthcare sector, has carved a niche as a leading manufacturer of specialty and generic drugs. With a substantial..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Evaluating an 87.25% Potential Upside in the Biotech Arena

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, has captured investor attention with its promising pipeline and significant potential upside. With a..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Evaluating Growth Potential and Analyst Sentiment

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a formidable presence in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of..

BioNTech SE (BNTX) Stock Analysis: Navigating a 42.75% Potential Upside in the Biotechnology Sector

Investors with a keen interest in the biotechnology sector may find BioNTech SE (NASDAQ: BNTX) an intriguing opportunity. This German healthcare giant, known for its groundbreaking..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: Impressive Revenue Growth and 22.93% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering force in the biotechnology sector, is capturing significant investor attention due to its remarkable revenue growth and substantial potential..

Tempus AI, Inc. (TEM) Stock Analysis: Unpacking the 42.59% Potential Upside Amidst Healthcare Tech Revolution

Tempus AI, Inc. (TEM), a prominent player in the healthcare technology sector, is garnering significant attention from investors, thanks to its innovative approach to health information..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 27.81% Potential Upside with Strong Buy Ratings

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has emerged as a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in..

Boston Scientific Corporation (BSX) Stock Analysis: A 32.89% Potential Upside Beckons Investors

Boston Scientific Corporation (NYSE: BSX), a titan in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a notable potential upside of..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating the Biotech Giant’s Growth Potential and Analyst Ratings

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a formidable player in the biotechnology sector, with a market capitalization of $82.28 billion and a diverse portfolio of..

Exelixis, Inc. (EXEL): Investor Outlook on a Biotech Powerhouse with a 30.56% Return on Equity

Exelixis, Inc. (NASDAQ: EXEL) is a prominent player in the biotechnology sector, with a specific focus on oncology, developing and commercializing medicines for challenging cancer types...

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating 12.27% Potential Upside with Strong Buy Ratings

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry, stands as a prominent investment option within the healthcare sector. With a market..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 19% Upside Potential Amidst Revenue Challenges

As individual investors assess the landscape of biotechnology stocks, Moderna, Inc. (NASDAQ: MRNA) presents an intriguing case. With its current market cap standing at $12.06 billion,..

Pfizer, Inc. (PFE) Stock Analysis: Potential 13.67% Upside with a Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, is known for its innovative approach in the drug manufacturing industry. With a market capitalization of..

Stryker Corporation (SYK) Stock Analysis: Unpacking the 22.96% Potential Upside

Stryker Corporation (NYSE: SYK), a stalwart in the healthcare sector, is catching the eyes of investors with its robust market presence and promising growth prospects. With..

DaVita Inc. (DVA) Stock Analysis: Exploring a 26% Potential Upside for Investors

DaVita Inc. (NYSE: DVA) is making waves in the healthcare sector, with a market capitalization of $8.19 billion. Specializing in kidney dialysis services, this Denver-based company..

Dr. Reddy’s Laboratories Ltd (RDY): Growth Potential and Analyst Consensus Highlight Investment Opportunities

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector and a key figure in the drug manufacturing industry, is drawing attention from..

Genmab A/S (GMAB) Stock Analysis: Strong Upside Potential with 18.84% on the Horizon

Genmab A/S (GMAB), a Danish biotechnology powerhouse, stands out in the healthcare sector with a robust market capitalization of $19.73 billion. Known for its innovative antibody-based..

Waters Corporation (WAT) Stock Analysis: Solid Performance in Diagnostics & Research with 6.38% Upside Potential

Waters Corporation (NYSE: WAT), a key player in the Healthcare sector, particularly within the Diagnostics & Research industry, is making waves with its robust financial metrics..

Tenet Healthcare Corporation (THC) Stock Analysis: A Promising 18.95% Upside for Investors

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable entity in the medical care facilities industry, boasting a diverse portfolio of services and a strong market..

Baxter International Inc. (BAX) Stock Analysis: Exploring the 21.37% Potential Upside Amid Turbulent Financials

Baxter International Inc. (NYSE: BAX) represents a compelling case study for investors navigating the healthcare sector. With a market capitalization of $10.02 billion, Baxter operates in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds